The bipartisan duo attempting to modify the FDA’s deeming regulations in the US Congress reacted with cautious optimism to commissioner Scott Gottlieb’s sweeping new policy plan, which many see as a nod for safer alternatives to traditional tobacco products. ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section